TRIP12 and breast carcinoma: Lastly, distant metastasis-free survival is lower (p value = 0.03563; COX p value = 0.26621; HR = 0.70(95% CI: 0.37–1.32)) in TRIP12 low tumors than in TRIP12 high tumors in the GSE7390 breast cancer study (Fig. 1c).